Scientists have discovered the signaling pathway whereby a master regulator of cancer cell proteins — known as Src — leads to ovarian cancer progression when exposed to stress hormones. The researchers report that beta blocker drugs mitigate this effect and reduce cancer deaths by an average of 17 percent.